Lite Strategy Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.18

+0.01 (+0.85%)

As of Mar 23, 10:11 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,124.6% upside

Low Target $26.78

Average Target $38.05

High Target $46.02

Current Price $1.18

Current
$1.18

Target
$38.05

$26.78 $38.05 avg $46.02

Scenario Analysis

Bear Case

$26.78

2,169.5%

Low target

Base Case

$38.05

+3,124.6%

Avg target

Bull Case

$46.02

+3,800.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$9.00

-86.9% from high

52-Week Low

$0.95

+24.1% from low

Target vs 52W High

$38.05

+322.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%